Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

156.77 +0.65 (+0.42%)
Official Closing Price Updated: 4:10 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,675,606
Open 156.64
Bid (Size) 156.11 (1)
Ask (Size) 156.77 (1)
Prev. Close 156.12
Today's Range 155.10 - 157.05
52wk Range 134.09 - 175.91
Shares Outstanding N/A
Dividend Yield 3.32%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
4 Top Value Stock ETFs for Long-Term Wealth Building
It could be value's time to shine for the first time in years. 
Via The Motley Fool
This Is What Whales Are Betting On AbbVie
 
Via Benzinga

Performance

YTD
-3.45%
-3.45%
1 Month
+3.14%
+3.14%
3 Month
-2.92%
-2.92%
6 Month
+9.89%
+9.89%
1 Year
-2.05%
-2.05%

More News

Read More
(ABBV) - Analyzing AbbVie's Short Interest
Via Benzinga
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
Via Investor's Business Daily
2 Growth Stocks to Buy Before the Bull Market Arrives
Via The Motley Fool
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
Via Benzinga
Is It Too Late to Buy AbbVie Stock?
Via The Motley Fool
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
Oracle, AbbVie And This Gold Fund: CNBC's 'Final Trades'
Via Benzinga
Dividend Income Update February 2023
Via Talk Markets
5 Forever Dividend Stocks
Via The Motley Fool
Diversify Your Income with These 2 High-Yielding Dividend ETFs
Via MarketBeat
Topics ETFs
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in March
Via The Motley Fool
Reap Monthly Income With This Combination Of 3 Stocks
Via Talk Markets
3 Surefire Stocks That Are Screaming Buys in March
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
How to Pick the Best Dividend Stocks
Via MarketBeat
Topics Economy
Exposures Interest Rates
The Stock That Tripled in a Day...And May Not Be Done
Via MarketBeat
7 Dividend Kings to Buy for an Uncertain Market Environment
Via InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
Via Talk Markets
2 High-Yield Dividend Stocks to Buy in March
Via The Motley Fool
Could This Humira Biosimilar Be a Winner for Amgen?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.